On Sep 9, 2021 Blue Note Therapeutics closed a Series A round and raised $5,200,000 from Alumni Ventures Group, Jazz Venture Partners, Memorial Sloan – […]
Series B – Lycia Therapeutics
On Sep 9, 2021 Lycia Therapeutics closed a Series B round and raised $70,000,000 from Alexandria Venture Investments, Cowen Healthcare Investments, Eli Lilly, Invus, Redmile […]
Series G – RareCyte
On Sep 9, 2021 RareCyte closed a Series G round and raised $24,000,000 from 5AM Ventures, Agilent Technologies, Arboretum Ventures, F-Prime Capital, HealthQuest Capital, Logos […]
Series B – Flo Health
On Sep 9, 2021 Flo Health closed a Series B round and raised $50,000,000 from Target Global, VNV Global, featuring lead investors Target Global, VNV […]
Post-IPO Equity – Bluebird Bio
On Sep 8, 2021 Bluebird Bio closed a Post-IPO Equity round and raised $75,000,000 from investors, featuring lead investors . About the company: Bluebird Bio […]
Debt Financing – Spiber
On Sep 8, 2021 Spiber closed a Debt Financing round and raised ¥10,000,000,000 from MUFG Bank, featuring lead investors MUFG Bank. About the company: Spiber […]
Venture Round – Haemalogix
On Sep 8, 2021 Haemalogix closed a Venture – Series Unknown round and raised A$10,000,000 from Platinum Asset Management, featuring lead investors Platinum Asset Management. […]
Series A – Replicate Bioscience
On Sep 8, 2021 Replicate Bioscience closed a Series A round and raised $40,000,000 from Apple Tree Partners, featuring lead investors Apple Tree Partners. About […]
Series B – Attralus
On Sep 8, 2021 Attralus closed a Series B round and raised $116,000,000 from Janus Henderson Investors, Logos Capital, Redmile Group, Samsara BioCapital, Sarissa Capital […]
Series B – PetMedix
On Sep 8, 2021 PetMedix closed a Series B round and raised £27,000,000 from Cambridge Innovation Capital, Digitalis Ventures, Kyoritsu Corporation, Parkwalk Advisors, Tencent, featuring […]
